Akademik Veri Yönetim Sistemi
Experimental and Clinical Transplantation, cilt.21, sa.2, ss.123-131, 2023 (SCI-Expanded)
Objectives: Sarcopenia is an important metabolic disorder associated with end-stage liver disease and is an independent predictor of mortality in liver transplant candidates. We evaluated effects of pretransplant muscle mass, muscle quality, and visceral adipose tissue on mortality after liver transplant. Materials and Methods: For 2015-2020, we included 65 liver transplant recipients whose records contained pretransplant liver computed tomography images. We calculated skeletal muscle mass index (muscle tissue area in centimeters squared divided by height in meters squared), visceral-to-subcutaneous fat ratio (visceral adiposity indicator), and intramuscular adipose tissue content ratio (muscle quality indicator). Results: Median age was 55 years (IQR, 45-63 years), and 48 (73.8%) patients were men. During follow-up, 53 (81.5%) study group patients survived; mean survival time was 71.73 ± 3.81 months. The deceased patient group had a statistically higher pretransplant visceral-to-subcutaneous fat ratio than the survival group (P =.046). Survival was 100% for 1 positive indicator, 86.2% for 2 positive indicators, and 70.4% for 3 positive indicators (P =.096). Positive correlation was confirmed between pretransplant skeletal muscle mass index and age (P =.043) and pretransplant body mass index (weight in kilograms divided by height in meters squared) (P <.001). There was a moderate positive correlation between pretransplant intramuscular adipose tissue content ratio and age (R = 0.529, P ≤.001) and a weak positive correlation with pretransplant body mass index (R = 0.361, P =.003). Furthermore, pretransplant visceral-to-subcutaneous fat ratio showed a weak positive correlation with age (R = 0.306, P =.013) and a weak negative correlation with the Model for End-Stage Liver Disease score (R =-0.301, P =.016). Conclusions: Pretransplant sarcopenia is an important indicator to predict mortality and morbidity in posttransplant follow-up. Visceral-to-subcutaneous fat ratio is an important parameter to evaluate sarcopenia in liver transplant patients.